3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
2
Completed
2
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
30
Thoracic
11
Head & Neck
8
Breast
8
Genitourinary
6
Gynecologic
3
Dermatologic
2
Sarcoma
1
CNS
1
Conditions
Melanoma
312
Carcinoma, Basal Cell
60
Skin Neoplasms
52
Lymphoma, T-Cell, Cutaneous
37
Breast Neoplasms
31
Uveal Melanoma
29
Neoplasms
27
Lung Neoplasms
27
Carcinoma, Non-Small-Cell Lung
27
Keratosis, Actinic
25
Neoplasm Metastasis
24
Carcinoma, Squamous Cell
22
Carcinoma, Renal Cell
21
Lymphoma
17
Mycosis Fungoides
16
Lymphoma, Large B-Cell, Diffuse
15
Hodgkin Disease
15
Urinary Bladder Neoplasms
14
Sezary Syndrome
14
Pancreatic Neoplasms
14
Lymphoma, Non-Hodgkin
14
Lymphoma, Follicular
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Ovarian Neoplasms
13
Lymphoma, Mantle-Cell
13
Lymphoma, B-Cell, Marginal Zone
13
Colorectal Neoplasms
13
Burkitt Lymphoma
13
Lymphoma, Large-Cell, Immunoblastic
12
Interventions
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Neoplastic Cells, Circulating
×
Dermatologic
×
Clear all
NCT03797053
2019-01-08
EXPEVIVO-CTC
Assistance Publique - Hôpitaux de Paris
Unknown
450 enrolled
NCT01565837
2016-02-01
SART
Comprehensive Cancer Centers of Nevada
Phase 2
Unknown
50 enrolled